BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 35346367)

  • 1. Engineering strategies for customizing extracellular vesicle uptake in a therapeutic context.
    Esmaeili A; Alini M; Baghaban Eslaminejad M; Hosseini S
    Stem Cell Res Ther; 2022 Mar; 13(1):129. PubMed ID: 35346367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular Uptake of Engineered Extracellular Vesicles: Biomechanisms, Engineered Strategies, and Disease Treatment.
    Xie Q; Hao Y; Li N; Song H; Chen X; Zhou Z; Wang J; Zhang Y; Li H; Han P; Wang X
    Adv Healthc Mater; 2024 Jan; 13(2):e2302280. PubMed ID: 37812035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Extracellular Vesicles as Delivery Systems in Therapeutic Applications.
    Wang L; Wang D; Ye Z; Xu J
    Adv Sci (Weinh); 2023 Jun; 10(17):e2300552. PubMed ID: 37080941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered extracellular vesicles and their mimetics for clinical translation.
    Kim H; Kim D; Nam H; Moon S; Kwon YJ; Lee JB
    Methods; 2020 May; 177():80-94. PubMed ID: 31626895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles.
    Zhuo Z; Wang J; Luo Y; Zeng R; Zhang C; Zhou W; Guo K; Wu H; Sha W; Chen H
    Acta Biomater; 2021 Oct; 134():13-31. PubMed ID: 34284151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
    Nasiri Kenari A; Cheng L; Hill AF
    Methods; 2020 May; 177():103-113. PubMed ID: 31917274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of Extracellular Vesicle Surfaces: An Approach for Targeted Drug Delivery.
    Mohammadi AH; Ghazvinian Z; Bagheri F; Harada M; Baghaei K
    BioDrugs; 2023 May; 37(3):353-374. PubMed ID: 37093521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered extracellular vesicles and their mimics in cardiovascular diseases.
    Lai J; Huang C; Guo Y; Rao L
    J Control Release; 2022 Jul; 347():27-43. PubMed ID: 35508222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methods, Mechanisms, and Application Prospects for Enhancing Extracellular Vesicle Uptake.
    Xu YP; Jiang T; Yang XF; Chen ZB
    Curr Med Sci; 2024 Apr; 44(2):247-260. PubMed ID: 38622425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Evaluation of Factors Affecting Extracellular Vesicle Uptake by Breast Cancer Cells.
    Stranford DM; Hung ME; Gargus ES; Shah RN; Leonard JN
    Tissue Eng Part A; 2017 Nov; 23(21-22):1274-1282. PubMed ID: 28586292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking.
    Murphy DE; de Jong OG; Brouwer M; Wood MJ; Lavieu G; Schiffelers RM; Vader P
    Exp Mol Med; 2019 Mar; 51(3):1-12. PubMed ID: 30872574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicle Uptake Assay via Confocal Microscope Imaging Analysis.
    Kim CJ; Kuczler MD; Dong L; Kim J; Amend SR; Cho YK; Pienta KJ
    J Vis Exp; 2022 Feb; (180):. PubMed ID: 35225262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Challenges and Possibilities of Extracellular Vesicles as Therapeutic Vehicles.
    Melling GE; Carollo E; Conlon R; Simpson JC; Carter DRF
    Eur J Pharm Biopharm; 2019 Nov; 144():50-56. PubMed ID: 31419585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-culture engineering: a promising strategy for production of engineered extracellular vesicle for osteoarthritis treatment.
    Esmaeili A; Hosseini S; Baghaban Eslaminejad M
    Cell Commun Signal; 2024 Jan; 22(1):29. PubMed ID: 38200606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-engineered extracellular vesicles for targeted delivery of therapeutic RNAs and peptides for cancer therapy.
    Jayasinghe MK; Pirisinu M; Yang Y; Peng B; Pham TT; Lee CY; Tan M; Vu LT; Dang XT; Pham TC; Chen H; Leung AYH; Cho WC; Shi J; Le MT
    Theranostics; 2022; 12(7):3288-3315. PubMed ID: 35547755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining tropism and activity of natural and engineered extracellular vesicles.
    Choi W; Park DJ; Eliceiri BP
    Front Immunol; 2024; 15():1363185. PubMed ID: 38660297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomimetic synthesis and optimization of extracellular vesicles for bone regeneration.
    Song X; Xu L; Zhang W
    J Control Release; 2023 Mar; 355():18-41. PubMed ID: 36706840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicles as Drug Delivery Vehicles to the Central Nervous System.
    Shahjin F; Chand S; Yelamanchili SV
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):443-458. PubMed ID: 31485884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.